CRMD
CorMedix Inc
Price:  
8.77 
USD
Volume:  
918,118.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRMD WACC - Weighted Average Cost of Capital

The WACC of CorMedix Inc (CRMD) is 8.3%.

The Cost of Equity of CorMedix Inc (CRMD) is 11.85%.
The Cost of Debt of CorMedix Inc (CRMD) is 5.00%.

Range Selected
Cost of equity 9.80% - 13.90% 11.85%
Tax rate 3.30% - 10.10% 6.70%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.3% - 9.2% 8.3%
WACC

CRMD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.3 1.61
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.80% 13.90%
Tax rate 3.30% 10.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.3% 9.2%
Selected WACC 8.3%